Be Biopharma
ID: 7354681Be Biopharma is developing a proprietary class of engineered B cells as medicines in applications beyond cytotoxicity.
3
Funding Rounds
$264.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Be Biopharma has raised a total of $264m in funding over 3 rounds.
Key Insights:
- Be Biopharma October 2024 Venture - Series Unknown Funding Round: $82m
- Be Biopharma Series B round, April 2022: $130m
- Be Biopharma Series A round, October 2020: $52m
Industries
Be Biopharma is active in the following industries: